Table 4.

Therapeutic parameters and outcome of the patients (n = 20).

Variable	Total n (%)	Severe group n (%)	Non-severe group n (%)	P-value
Type of antibiotic used				0.07
Metronidazole	10 (50%)	8 (57.1%)	2 (33.3%)
Combined Metronidazole and Penicillin	8 (40%)	6 (42.9%)	2 (33.3%)
Other antibiotic	2 (10%)	0	2 (33.3%)
ICU admission (Yes/No)				0.0004
Yes	15 (75%)	14 (100%)	1 (16.7%)
No	5 (25%)	0	5 (83.3%)
Debridement after admission				0.0007
Yes	12 (60%)	12 (85.7%)	0
No	8 (40%)	2 (14.3%)	6 (100%)
Invasive mechanical ventilation				0.0002
Yes	13 (65%)	13 (92.9%)	0
No	7 (35%)	1 (7.1%)	6 (100%)
Heavy sedation combined with muscle relaxants				0.0007
Yes	12 (60%)	12 (85.7%)	0
No	8 (40%)	2 (14.3%)	6 (100%)
Feeding after pylorus				0.12
Yes	6 (30%)	6 (42.9%)	0
No	14 (70%)	8 (57.1%)	6 (100%)
Pulmonary infection				0.16
Yes	12 (60%)	10 (71.4%)	2 (33.3%)
No	8 (40%)	4 (28.6%)	4 (66.7%)
Sequela				1.0
Yes	2 (10%)	2 (14.3%)	0
No	18 (90%)	12 (85.7%)	6 (100%)
Hospital stay (d) median (IQR†)	29.5 (12–68)	33 (21–68)	17.5 (12–31)	0.008